Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Burosumab granted FDA orphan drug status for tumor-induced osteomalacia syndrome

June 22, 2017

AbbVie's lutikizumab fails primary endpoint in a phase IIa trial for hand OA

June 21, 2017

Biocad's BCD-055 demonstrates equivalence to infliximab in clinical trials

June 21, 2017

Seikagaku initiates phase II study in U.S. with SI-613 for knee osteoarthritis

June 19, 2017

Human pluripotent stem cells used for cartilage repair in animal models

June 19, 2017

Mitsubishi Tanabe Pharma discovers MC1 receptor agonists

June 16, 2017

ACEA completes phase I trial of AC-0058

June 15, 2017

FDA grants rare pediatric disease designation to Fibrocell Science's FCX-013

June 13, 2017

Medivir gives update on phase IIa extension study of MIV-711

June 12, 2017

Upadacitinib meets all primary and secondary endpoints in phase III SELECT-NEXT study

June 9, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld
Hematopoietic stem cell research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...